Awareness and control rates of diabetes and hyperlipidemia in hypertensive cerebral infraction patients
10.3969/j.issn.1671-8283.2017.10.006
- VernacularTitle:高血压性脑梗死患者合并糖尿病和高脂血症及其疾病知晓率和控制率的现状
- Author:
Cuiling OU
1
;
Chanchan WU
;
Youai AO
;
Miaomiao MO
;
Ling LI
;
Lihong WAN
Author Information
1. 中山大学附属第三医院神经内科
- Keywords:
hypertension;
cerebral infraction;
diabetes;
hyperlipidemia;
treatment
- From:
Modern Clinical Nursing
2017;16(10):25-30
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the prevalence of diabetes and hyperlipidemia in cerebral infraction patients with hypertension and look into the rates of awareness, treatment and control. Methods Blood pressure, blood glucose and blood lipids were measured in 238 cerebral infraction patients with hypertension. Meanwhile, the rate of awareness, treatment and control of hypertension, diabetes and hyperlipidemia were investigated by questionnaire. Results Among 79.41％of the patients had abnormal blood pressure and cerebral infaction on admission, the rates of awareness , treatment and control of hypertension were 74.79％, 67.23％, 20.59％. 10.11％of them never took antihypertensive drugs in spite of their awareness of hypertension. 32.35％ of the patients were combined with diabetes, the rates of awareness, treatment and control were 79.22％, 62.34％, 12.99％respectively, and among them 21.31％never tookantidiabetic drugs in spite of awareness of diabetes. 81.51％ of the patients were combined with hyperlipidemia, the rates of awareness, treatment and control were 23.20％, 6.70％, 1.55％respectively, and among them 71.11％never took lipid-lowering drugs with awareness of high blood lipid. Conclusions 79.41％ of the incidence of cerebral infraction was related to abnormal blood pressure. 32.35％cerebral infarction patients with hyperlipdemioa are complicated with hypertension diabetes;81.51％are complicated with 28.57％cerebral infraction patients with hypertension were complicated with diabetes and hyperlipidemia as well, but the rate of awareness, treatment and control were relatively low. In order to improve the secondary prevention, we should pay more attention to the stroke risk factors, and help make the individualized medicine-taking plan to improve the control rate.
